A recent publication (Yurttas et al, PMID: 30572653) illustrated the dilemma of the empirical HIPEC protocols: only for colorectal cancer, 62 different chemotherapy protocols were published, making a comparison of data challenging. So far, only a handful of PIPAC protocols are used but PIPAC is clearly on the “verge of diversification”. Efforts are needed to maintain homogenous treatment protocols for PIPAC allowing standardized training, design of homogeneous multicentric prospective randomized trials, and comparison/merging of datasets.
Prof. Martin Hübner, MD (Lausanne, Switzerland), and Dr. Olivia Sgarbura, MD PhD (Montpellier, France) are organizing a consensus meeting on PIPAC chemotherapy regimen in Paris on July 2nd-3rd, 2021. They are supported by Prof. Marc Pocard, MD PhD (Paris, France) and Prof. Clarisse Eveno, MD PhD (Lille, France). Invited participants are leading surgeons, medical oncologists, and pharmacologist active in the field of peritoneal metastasis. After publication in a peer-reviewed journal, results of the consensus meeting will be published on this website
The consensus meeting is supported by an unrestricted educational grant from SMD medical, Tägerwilen, Switzerland